These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31750595)

  • 61. Risk of Development of Second Primary Head and Neck Cancer following an Index Breast Cancer.
    Yesensky J; Kyrillos A; Kuchta K; Yao K; Wang CH; Bhayani MK
    Otolaryngol Head Neck Surg; 2018 Feb; 158(2):303-308. PubMed ID: 29039234
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Nutrition impact symptoms and associated outcomes in post-chemoradiotherapy head and neck cancer survivors: a systematic review.
    Crowder SL; Douglas KG; Yanina Pepino M; Sarma KP; Arthur AE
    J Cancer Surviv; 2018 Aug; 12(4):479-494. PubMed ID: 29556926
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Survival of patients with head and neck cancer with metachronous multiple primary tumors is surprisingly favorable.
    Bugter O; van Iwaarden DLP; Dronkers EAC; de Herdt MJ; Wieringa MH; Verduijn GM; Mureau MAM; Ten Hove I; van Meerten E; Hardillo JA; Baatenburg de Jong RJ
    Head Neck; 2019 Jun; 41(6):1648-1655. PubMed ID: 30652377
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Second primary tumours in head and neck cancer.
    Herranz González-Botas J; Varela Vázquez P; Vázquez Barro C
    Acta Otorrinolaringol Esp; 2016; 67(3):123-9. PubMed ID: 26386656
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Multiple primary cancers in Hong Kong Chinese patients with squamous cell cancer of the head or neck.
    Choy AT; van Hasselt CA; Chisholm EM; Williams SR; King WW; Li AK
    Cancer; 1992 Aug; 70(4):815-20. PubMed ID: 1643613
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Survival in second primary malignancies of patients with head and neck cancer.
    Di Martino E; Sellhaus B; Hausmann R; Minkenberg R; Lohmann M; Esthofen MW
    J Laryngol Otol; 2002 Oct; 116(10):831-8. PubMed ID: 12437840
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590).
    Bhatia AK; Lee JW; Pinto HA; Jacobs CD; Limburg PJ; Rubin P; Arusell RM; Dunphy EP; Khandekar JD; Reiner SA; Baez-Diaz L; Celano P; Li S; Li Y; Burtness BA; Adams GL; Pandya KJ
    Cancer; 2017 Dec; 123(23):4653-4662. PubMed ID: 28786105
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Role of routine panendoscopy in cancer of the upper aerodigestive tract.
    Stoeckli SJ; Zimmermann R; Schmid S
    Otolaryngol Head Neck Surg; 2001 Feb; 124(2):208-12. PubMed ID: 11226943
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Second primary tumors following tobacco dependence treatments among head and neck cancer patients.
    Garces YI; Schroeder DR; Nirelli LM; Croghan GA; Croghan IT; Foote RL; Hurt RD
    Am J Clin Oncol; 2007 Oct; 30(5):531-9. PubMed ID: 17921716
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Incidence of second primary malignancies in patients with treated head and neck cancer: a comprehensive review of literature.
    Atienza JA; Dasanu CA
    Curr Med Res Opin; 2012 Dec; 28(12):1899-909. PubMed ID: 23121148
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effectiveness of planned surveillance for detecting second primary head and neck cancers after endoscopic resection of esophageal squamous cell carcinoma.
    Shinozaki T; Katada C; Shiga K; Asakage T; Yokoyama T; Yano T; Oda I; Shimizu Y; Takemura K; Ishikawa H; Yokoyama A; Muto M
    Jpn J Clin Oncol; 2020 Sep; 50(10):1162-1167. PubMed ID: 32533160
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clinical impact of surveillance for head and neck cancer in patients with esophageal squamous cell carcinoma.
    Morimoto H; Yano T; Yoda Y; Oono Y; Ikematsu H; Hayashi R; Ohtsu A; Kaneko K
    World J Gastroenterol; 2017 Feb; 23(6):1051-1058. PubMed ID: 28246479
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Second primary cancers in pediatric head and neck cancer survivors in Denmark during 1980-2014: A nationwide study.
    Schmidt Jensen J; Grønhøj C; Ruud Kjær EK; Charabi BW; von Buchwald C; Hjuler T
    Int J Pediatr Otorhinolaryngol; 2019 Dec; 127():109648. PubMed ID: 31472358
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Treatment for synchronous and metachronous carcinomas of the head and neck and esophagus.
    Tachimori Y; Watanabe H; Kato H; Ebihara S; Ono I; Nakatsuka T; Harii K
    J Surg Oncol; 1990 Sep; 45(1):43-5. PubMed ID: 2381213
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Survival of second and multiple primary tumors in patients with oral cavity squamous cell carcinoma in the betel quid chewing area.
    Liao CT; Kang CJ; Chang JT; Wang HM; Ng SH; Hsueh C; Lee LY; Lin CH; Cheng AJ; Chen IH; Huang SF; Yen TC
    Oral Oncol; 2007 Sep; 43(8):811-9. PubMed ID: 17174143
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Trends over three decades of the risk of second primary cancer among patients with head and neck cancer.
    Jégu J; Binder-Foucard F; Borel C; Velten M
    Oral Oncol; 2013 Jan; 49(1):9-14. PubMed ID: 22840787
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Second malignant neoplasms in patients with head and neck squamous cell carcinomas.
    Boysen M; Loven JO
    Acta Oncol; 1993; 32(3):283-8. PubMed ID: 8323766
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Multiple synchronous and metachronous cancers of the upper aerodigestive tract: a nine-year study.
    Panosetti E; Luboinski B; Mamelle G; Richard JM
    Laryngoscope; 1989 Dec; 99(12):1267-73. PubMed ID: 2601541
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Risk of second primary tumors in GIST survivors: A systematic review and meta-analysis.
    Petrelli F; Tomasello G; Barni S; Varricchio A; Costanzo A; Rampulla V; Cabiddu M; Turati L; Russo A; Seghezzi S; Passalacqua R; Ghidini M
    Surg Oncol; 2019 Jun; 29():64-70. PubMed ID: 31196495
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The risk of second primary tumors in patients with nasopharyngeal carcinoma after definitive radiotherapy.
    Kong L; Lu JJ; Hu C; Guo X; Wu Y; Zhang Y
    Cancer; 2006 Sep; 107(6):1287-93. PubMed ID: 16909425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.